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Abstract
Background: Epidemiological studies have linked the consumption of chlorinated surface waters
to an increased risk of two major causes of human mortality, colorectal and bladder cancer.
Trihalomethanes (THMs) are by-products formed when chlorine is used to disinfect drinking water.
The purpose of this study was to examine the ability of the THMs, trichloromethane (TCM),
bromodichloromethane (BDCM), dibromochloromethane (DBCM), and tribromomethane (TBM),
to induce DNA strand breaks (SB) in (1) CCRF-CEM human lymphoblastic leukemia cells, (2)
primary rat hepatocytes (PRH) exposed in vitro, and (3) rats exposed by gavage or drinking water.
Methods: DNA SB were measured by the DNA alkaline unwinding assay (DAUA). CCRF-CEM
cells were exposed to individual THMs for 2 hr. Half of the cells were immediately analyzed for
DNA SB and half were transferred into fresh culture medium and incubated for an additional 22 hr
before testing for DNA SB. PRH were exposed to individual THMs for 4 hr then assayed for DNA
SB. F344/N rats were exposed to individual THMs for 4 hr, 2 weeks, and to BDCM for 5 wk then
tested for DNA SB.
Results: CCRF-CEM cells exposed to 5- or 10-mM brominated THMs for 2 hr produced DNA
SB. The order of activity was TBM>DBCM>BDCM; TCM was inactive. Following a 22-hr recovery
period, all groups had fewer SB except 10-mM DBCM and 1-mM TBM. CCRF-CEM cells were
found to be positive for the GSTT1-1 gene, however no activity was detected. No DNA SB,
unassociated with cytotoxicity, were observed in PRH or F344/N rats exposed to individual THMs.
Conclusion: CCRF-CEM cells exposed to the brominated THMs at 5 or 10 mM for 2 hr showed
a significant increase in DNA SB when compared to control cells. Additionally, CCRF-CEM cells
exposed to DBCM and TBM appeared to have compromised DNA repair capacity as demonstrated
by an increased amount of DNA SB at 22 hr following exposure. CCRF-CEM cells were found to
be positive for the GSTT1-1 gene, however no activity was detected. No DNA SB were observed
in PRH or F344/N rats exposed to individual THMs.
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Background
Trihalomethanes (THMs) are by-products formed when
chlorine is used to disinfect drinking water [1,2]. Trichlo-
romethane (TCM) is most often the predominant THM
formed during chlorine disinfection; however, the bromi-
nated methanes, bromodichloromethane (BDCM),
dibromochloromethane (DBCM), and tribromomethane
(TBM) may be formed at levels comparable to or exceed-
ing that of chloroform depending on the concentration of
bromine in the water [3]. Total THM concentrations in
finished drinking water typically range from 10–100 µg/L
in the United States [3]. Epidemiological studies have
linked the consumption of chlorinated surface waters to
an increased risk of two major causes of human mortality
in the United States, colorectal and bladder cancer [4,5].
Recent studies have suggested that exposure to bromi-
nated trihalomethanes poses a greater human health risk
than exposure to chloroform. Studies in Salmonella have
shown that brominated THMs are metabolized by GSTT1-
1 into mutagenic compounds [6,7]. Additionally, F344/N
rats exposed to brominated THMs in drinking water devel-
oped colonic aberrant crypt foci (ACF) [8,9]. ACF are con-
sidered to be early putative preneoplastic lesions of colon
neoplasia [10,11].
Chloroform has been uniformly negative in genetic toxic-
ity assays, whereas the data for the genotoxicity of the bro-
minated THMs have been mixed [12]. The purpose of this
study was to examine the ability of the THMs to induce
DNA strand breaks (SB) in (1) CCRF-CEM human lym-
phoblastic leukemia cells, (2) rat hepatocytes exposed in
vitro, and (3) rats exposed by gavage or drinking water.




Bromodichloromethane (BDCM; 98+% stabilized with
potassium carbonate; CAS 75-27-4), dibromochlo-
romethane (DBCM; 98+%; CAS 124-48-1), tribro-
momethane (TBM; 99+%; CAS 75-25-2), methyl
methanesulfonate (MMS; CAS 66-27-3), and dimethylni-
trosamine (DMNA; CAS 62-75-9) were purchased from
Aldrich Chemical Co. (Milwaukee, WI). Trichlorometh-
ane (TCM; 99+%; CAS 67-66-3) was obtained from Fisher
Scientific Co. (Cincinnati, OH). Sodium lauryl sarcosi-
nate (SLS), dithiothreitol (DTT), ethylenediamine-tetrace-
tic acid (EDTA), collagenase Type IV and dexamethasone
were from Sigma Chemical Co. (St. Louis, MO). Williams
Medium E (WME), Hepes buffer (1 M), fetal bovine serum
(FBS), gentamicin and all other cell culture products were
purchased from GIBCO (Gand Island, NY). Hydroxylapa-
tite gel (HTP-DNA grade) was obtained from BioRad Lab-
oratories (Richmond, CA). Emulphor (a polyoxyethylated
vegatable oil) was from GAF Corp. (Linden, NJ). DNA-
specific Hoechst dye 33258 (Bisbenzimide) was pur-
chased from Calbiochem Behring Corp. (La Jolla, CA).
CCRF-CEM cell culture
The CCRF-CEM human lymphoblastic leukemia cell line
(American Type Culture Collection, Rockville, MD) was
grown in RPMI 1640 medium supplemented with 10%
FBS, 25 mM Hepes, 20-mM L-glutamine, and 50-µg/mL
gentamicin. The cells were suspended in culture medium
without serum at a concentration of 2 × 106 cells/mL, and
the test chemicals were added into 2 mL of this suspen-
sion. After a 2-hr exposure, the cells were centrifuged and
resuspended in 1 mL of ice cold PBS/EDTA and immedi-
ately subjected to the DNA SB assay. Viability of the cells
following treatment was determined by trypan blue exclu-
sion. In order to study the ability of the cells to recover
after removal of the test chemical, half of the cells follow-
ing the 2-hr exposure were centrifuged and resuspended
in fresh culture medium without the test chemical and
incubated for an additional 22 hr. The preparation of cells
for the DNA SB assay was the same as described for the 2-
hr treatment. CCRF-CEM cells are essentially devoid of
cytochrome P450 enzyme activity [13].
Rat hepatocyte isolation and culture
Rat hepatocytes were prepared by a two-step liver per-
fusion method [14] as modified by [15]. Isolated hepato-
cytes were suspended in Williams medium E (WME)
containing 10% FBS, 25-mM hepes, 2-mM L-glutamine,
30-nM dexamethasone, 0.5-µM insulin and 50-µg/mL
gentamicin. The cells were incubated for 2 hr at 37EC for
attachment, and the test chemicals were added in serum-
free medium. After 4-hr of treatment, the medium was
removed and tested for lactate dehydrogenase activity
(LDH; Sigma Kit No. 228) as an index of cytotoxicity. The
cell cultures were rinsed and scraped into 3 mL of ice cold
modified Seligmann Balanced Salt Solution (SBSS: 0.13-
M NaCl, 2.68-mM KCl, 17.8-mM sodium acetate, 0.36-
mM NaH2PO4, 0.73-mM KH2PO4, 5.55-mM D-glucose,
0.14-mM NaHCO3, 17-mM ascorbic acid, pH 7.2) freshly
supplemented with 10-mM DTT and 0.1% nonidet P-40
and were gently homogenized with a dounce homoge-
nizer. The cell pellets were then collected via centrifuga-
tion and resuspended in 1-mL PBS/EDTA for the DAUA
assay.
Animals and treatments
Male F344/N rats (250–300 g) were purchased from
Charles River (Wilmington, MA) and maintained on
Purina Laboratory Chow ad libitum. Rat exposures were
conducted in three stages: a single oral gavage of each
THM followed by sacrifice after 4 hr, a 2-week exposure of
each THM in drinking water and a 5-week exposure to
BDCM in drinking water. In the 4-hr study, test animalsJournal of Carcinogenesis 2004, 3 http://www.carcinogenesis.com/content/3/1/2
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received a single oral gavage dose of test compound (0.3
or 0.6 mM/kg) in deionized water or deionized water con-
taining 0.25% emulphor and sacrificed after 4 hr. Control
animals received the appropriate vehicle only. DMNA (2
mmol/kg) was used as the positive control compound. In
the 2-week study, rats were exposed to the test chemicals
(0.6, 1.2 or 2.4 g/L) in drinking water except TBM, which
was given in deionized water containing 0.25% emulphor
because of its low solubility in water. The control and sol-
vent control animals were given deionized water and
deionized water containing 0.25% emulphor, respec-
tively. In the 5-week study, rats were exposed to BDCM
(0.6, 1.2 or 2.4 g/L) in drinking water. Body weights and
water consumption were recorded for each exposure
group. All aspects of the studies were conducted in facili-
ties certified by the American Association for Accredita-
tion of Laboratory Animal Care in compliance with the
guidelines of that association and the NERL Animal Care
Committee.
Isolation of liver, kidneys and duodenum cells from rats
Treated rats were sacrificed and 1.5 g of the superior-ante-
rior lobe of the liver was used for cell isolation. The proce-
dure of liver cell isolation from rats for DAUA assay were
as follows. The livers were first pressed through a cold
stainless steel tissue press, mixed gently with 12-mL SBSS
and then filtered through an 8-layer cotton gauze pad. A
1-mL aliquot of liver cells was centrifuged at 100 × g and
resuspended in 1-mL ice cold PBS/EDTA for the DAUA
assay. The isolation of kidney cells was performed in a
similar manner. The preparation of duodenum epithelial
cells were as follows. A 5-cm segment of duodenum was
cut off and flushed with 5-mL of pH 9 buffer (0.114-M
Tris, 0.077-M NaCl, pH 9) at 0°C. The segments were cut
open, and the intestinal mucus membrane was scraped off
using a spatula. The cells were mixed with 5-mL of buffer
(pH 9) and drawn through a 12-gauge needle five times.
For the DAUA, 1-mL of this cell suspension was used.
DNA Alkaline Unwinding Assay (DAUA)
The DNA alkaline unwinding assay estimates the extent of
primary DNA damage based upon the fraction of single-
(ss) and double- (ds) stranded DNA. The following types
of DNA damage; alkali labile sites, adducts, oxidative
damage, dimers, depurinisation, depyrimidation, and
desamination have been shown to increase the amounts
of ss-DNA following alkaline denaturing (unwinding).
The fraction of ds-DNA remaining after alkaline treatment
is calculated by dividing the amount of ds-DNA by the
total (ss- plus ds-) DNA. This gives a fraction of DNA
remaining as ds-DNA and is used as an estimate of DNA
damage.
The DAUA was performed according to [16]. Briefly, the
treated cells were lysed in 1 mL of 0.1-N NaOH. The time
for the unwinding was 1 hr for CCRF-CEM cells and 45
min for primary rat hepatocytes, liver, kidney and intesti-
nal cells. Solutions were neutralized with 1 mL of 0.1-N
HCl and 0.25-mL of 2% SLS/20 mM EDTA followed by 5
sec of sonication. Single- (ss) and double- (ds) stranded
DNA were separated on a hydroxylapatite column at
60°C. Hoechst Dye 33258 was added at a concentration
of 4 × 10-7 M, and the amount of DNA in each fraction was
determined fluorimetrically using a Shimadzu RF-5000 U
spectrofluorometer set at an excitation wavelength of 350
nm and an emission wavelength 465 nm. The fraction (F)
of ds-DNA remaining after alkaline unwinding was calcu-
lated by dividing the amount of ds-DNA by the total (ss-
plus ds-) DNA.
The relationship between the F-value and the number of
DNA SB induced per cell (Ni) as a function of concentra-
tion or the test chemical has been determined previously
for CCRF-CEM cells [16,17]. The number of DNA SB
induced (Ni) per cell was calculated as Ni = -6.1 × 104 [ln
(FT/FO)], where Ni is the number of DNA SB per cell
induced, FT and FO are the F values for the treated cells and
control cells, respectively. The decrease in the natural log-
arithm of the F-value is inversely proportional to the
increase in the number of induced DNA SB. Due to the
quantitative and qualitative differences in the activity of
the DNA repair enzymes between cell and tissue types,
this equation should not be used to estimate (based on F-
value) the absolute number of DNA SB in other cell lines.
Nevertheless, the decreasing F-value indicates increasing
DNA SB in all cell types.
Multiplex PCR characterization of GSTT1-1
DNA was extracted from CCRF-CEM cells by using the
standard proteinase K, phenol/chloroform technique and
reconstituted in Tris-EDTA buffer (pH 8.0). DNA (100 –
400 ng titrations) was genotyped by multiplex polymerase
chain reaction (PCR) [18] with minor modifications.
GSTT1-1 was co-amplified with GSTM1 and beta globin as
an internal positive control. External controls included
samples from a subject with known positive genotype for
GSTT1-1 and GSTM1 and samples from a subject with
known null genotype for both enzymes. The Qiagen Hot-
Star Taq DNA Polymerase method was used to enhance
PCR and avoid cross-contamination from external hot-
starting. A final concentration of 6.2-mM magnesium
chloride was used in the reaction (total volume = 35 µl).
Five µL of PCR product was mixed with 2 µL load dye
(bromophenol blue, xylene cyanole, ficoll) and electro-
phoresed alongside a 50-base-pair ladder marker (Invitro-
gen, cat. no. 10416-014) in 1X Tris-Borate-EDTA pH 8.0
buffer on 1.5 % agarose, 0.5 µg/mL ethidium bromide gel
at 82 mA for 40 min. Gel was digitally photographed on
an ultra-violet lightbox using a Kodak Digital Camera
System.Journal of Carcinogenesis 2004, 3 http://www.carcinogenesis.com/content/3/1/2
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GSTT1-1 enzyme activity assay
Fresh human CCRF-CEM cells were harvested by centrifu-
gation (3,000 × g, 10 min) and the cells washed with cold
0.9% w/v saline. The washed cells were then resuspended
in 0.5 mL of ice-cold 10 mM potassium phosphate (pH
6.5) and sonicated on ice (4 pulses, 30 s per pulse). The
resulting homogenate was centrifuged at 20,000 × g (4°C,
30 min). The soluble fraction was filtered (0.22 µ) and
assayed for protein content by the method of Bradford.
The protein concentration of the extract was 7.37 mg/mL
and the GSTT1-1 activity toward the substrate 1,2-epoxy-
3-(4'-nitrophenoxy)propane (ENPP) was determined in
duplicate by a spectrophotometric assay described previ-
ously, using ∆ε = 0.5 mM-1 cm-1 [19]. B6C3F1 mouse liver
cytosol was used as a positive control for this assay (spe-
cific activity, 202.5 nmol/min/mg protein, n = 2).
Statistical analysis
Data were tested for normality, and a oneway analysis of
variance was performed on the group data. Analysis to
determine significant increases from corresponding treat-
ment controls was performed by a Dunnett's T-test at p <
0.05. Analysis was performed using SPSS version 11.0




ane (DBCM), and tribromomethane (TBM) at 5 or 10 mM
significantly induced DNA SB in CCRF-CEM cells after a 2-
hr exposure (Table 1). Trichloromethane (TCM) was inac-
tive in this study. MMS (0.5 mM), a direct-acting genoto-
xin used as the positive control chemical, induced
significant DNA SB in CCRF-CEM cells. There was no sig-
nificant decrease in cell viability among all concentrations
tested. MMS induced the most DNA SB at 50,020 SB/cell/
µM (56.01% damage), whereas TBM was the most potent
THM, inducing 16,800 and 34,030 SB/cell/µM (24.12 and
42.79% damage) at 5 and 10 mM, respectively. The num-
bers given for DNA SB induced per cell were calculated as
described by [16,17].
The ability of CCRF-CEM cells to recover following THM
exposure was examined by incubating the cells for an
additional 22 hr in fresh medium then analyzing for DNA
SB. DNA SB recovery was observed in TCM, BDCM at 1
and 5 mM and DBCM at 1 mM. Cell viability was also
increased for the prior mentioned THMs. However, 10-
mM DBCM and 1-mM TBM treated cells showed
increased levels of DNA damage, indicating lack of recov-
ery. Moreover, 5- and 10-mM TBM treated cells also
showed no recovery, however, these data are not consid-
ered biologically significant due to associated high cell
mortality that may be the result of secondary DNA
damage from cytotoxic injury. CCRF-CEM cells were pos-
itive for the presence of the GSTT1-1 gene (Fig. 1), how-
ever, GSTT1-1 activity was not detected in the soluble
Table 1: Results of DNA damage (measured as strand breaks by the DNA alkaline unwinding assay, DAUA) from CCRF-CEM cells 
exposed to methyl methanesulfonate (MMS), trichloromethane (TCM), bromodichloromethane (BDCM), dibromochloromethane 
(DBCM), and tribromomethane (TBM) for 2 hr.
Treatments Break/cell/µM (2 hr) %Damage (2 hr) Via Break/cell/µM (24 hr) %Damage (24 hr) Via %Recovery
Control --- 0 ± 0.54 94 --- 0 ± 1.29 96 ---
MMS-0.5 mM 50020 ± 2810* 56.01 ± 2.47* 89 12740 ± 450* 18.84 ± 2.87* 75 74.53
TCM-1 mM 1830 ± 43 3.02 ± 2.29 94 220 ± 3 0.39 ± 1.35 96 87.98
5 mM 3180 ± 33 5.13 ± 1.02 95 470 ± 11 0.82 ± 2.31 94 85.22
10 mM 1530 ± 17 2.51 ± 1.11 88 490 ± 4 0.82 ± 0.74 94 67.97
BDCM-1 mM 2010 ± 45 3.31 ± 2.14 92 0 -1.09 ± 2.07 96 100
5 mM 9290 ± 525* 14.17 ± 4.85* 92 0 -1.24 ± 1.52 92 100
10 mM 8590 ± 205* 13.19 ± 2.09* 87 2540 ± 31 4.16 ± 1.16 89 70.43
DBCM-1 mM 3220 ± 140 5.16 ± 4.11 91 0 -2.45 ± 0.70 92 100
5 mM 7440 ± 112* 11.55 ± 1.34* 86 4430 ± 128 7.03 ± 2.68 86 40.46
10 mM 14990 ± 870* 21.83 ± 4.53* 85 16920 ± 937* 24.24 ± 4.18* 76 -12.86
TBM-1 mM 3150 ± 43 5.13 ± 1.29 91 4280 ± 95 6.80 ± 2.07 85 -35.87
5 mM 16800 ± 22* 24.12 ± 0.10* 90 30490 ± 2110*† 39.36 ± 4.23* 45 -81.49
10 mM 34030 ± 1212* 42.79 ± 2.04* 78 53540 ± 6829*† 58.43 ± 5.30* 12 -57.33
*Significantly different when compared to control (p < 0.05) †These data are not considered significant due to associated high cell mortality that 
may be the result of secondary DNA damage from cytotoxic injury. Following exposure, half of the cells were immediately subjected to the DAUA, 
and the remaining half were suspended in fresh medium for 22 hr, then subjected to DAUA to access recovery. DNA damage is reported as breaks 
per cell for a given concentration and percent damage compared to control, ± standard error. Viability (Via) was performed by the trypan blue 
exclusion assay and is reported as the percent of living cells compared to control. The viability was 98% at the time of treatment. Recovery is 
reported as the percent difference between the 2 and 24 hr DNA damage count. Each treatment was run in triplicate.Journal of Carcinogenesis 2004, 3 http://www.carcinogenesis.com/content/3/1/2
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protein fraction by the spectrophotometric assay utilized
[19].
Rat hepatocyte trihalomethane exposure
Significant increases in DNA SB that were not associated
with cytotoxicity were not observed in primary rat hepato-
cytes (PRH) exposed to individual THMs for 4-hr.
Although significant increases in DNA SB were observed
at 10-mM DBCM and 10-mM TBM, this finding correlated
with high cell mortality and may be the result of second-
ary DNA damage from cytotoxic injury (Table 2). Cytotox-
icty was assessed by measuring the amount of cellular
lactate dehydrogenase (LDH) released at the conclusion
of the 4-hr exposure. MMS- (0.5 mM) exposed PRH pro-
duced levels of DNA SB similar to those observed in MMS-
exposed CCRF-CEM cells. BDCM at 10 mM and DBCM at
5 mM were cytotoxic to PRH, although no evidence of
DNA SB were observed. Similar to CCRF-CEM cells, TCM
did not produce significant DNA SB or cytotoxicity to
PRH.
Rat trihalomethane exposure
F344/N rats administered a single oral gavage dose of each
THM (0.3 or 0.6 mM/kg) in 0.5% emulphor and analyzed
4 hr later showed no DNA SB in liver, kidney, or duode-
num epithelial cells when compared to control animals.
Furthermore, in the 2-week study, only the positive con-
trol, DMNA (2 mM/kg), produced significant DNA SB in
rat liver and kidney epithelial cells but not in duodenum
epithelial cells. Rats exposed to BDCM (0.6, 1.2 or 2.4 g/
L) in drinking water for 5 weeks showed no induction of
appreciable DNA SB in liver, kidney, or duodenum epi-
thelial cells (data not shown).
Discussion
CCRF-CEM cells exposed to the brominated THMs at 5 or
10 mM for 2 hr showed a significant increase in DNA SB
when compared to control cells. TCM was inactive in this
study. At these concentrations, cell viability ranged from
78–94%. Following the 2-hr exposure, half of the exposed
cells were transferred to clean media for 22 hr then tested
for DNA SB. BDCM at 1 and 5 mM and DBCM at 1 mM
showed 100% DNA SB recovery; however, DBCM at 10
mM and TBM at 1 mM showed additional DNA SB. TBM
at 5- and 10-mM also showed additional DNA SB, how-
ever we do not believe this to be biologically significant
Multiplex PCR characterization of GSTT1-1 in CCRF-CEM cells Figure 1
Multiplex PCR characterization of GSTT1-1 in CCRF-CEM cells. GSTT1-1 was co-amplified with GSTM1 and beta globin as an 
internal positive control. Lanes A through E are CCRF-CEM cells at 50.5, 204, 408, 816, and 74 ng DNA, respectively. Lanes F 
and G are external controls (320 ng DNA) with lane F showing a subject positive for both GSTT1-1 and GSTM1 with lane G 
showing a subject null for both enzymes. DNA marker is a 50-bp ladder (Invitrogen).
Table 2: Primary rat hepatocytes (PRH) were exposed to methyl 
methanesulfonate (MMS-positive control), trichloromethane 
(TCM), bromodichloromethane (BDCM), 
dibromochloromethane (DBCM), and tribromomethane (TBM) 
for 4 hr.
Treatments % Damage LDH (% Max)
Control 0 ± 0.42 4 ± 0.18
MMS-0.5 mM 53.11 ± 4.13* 11 ± 0.72*
TCM-1 mM 0 4 ± 0.03
5 mM 0 6 ± 0.09
10 mM 0 5 ± 0.69
BDCM-1 mM 0 7 ± 0.57
5 mM 2.24 ± 4.31 11 ± 0.45
10 mM 3.39 ± 1.88 41 ± 0.87*
DBCM-1 mM 10.0 ± 4.25 7 ± 0.22
5 mM 8.64 ± 6.04 32 ± 3.10*
10 mM 71.58 ± 4.55*† 92 ± 1.27*
TBM-1 mM 0 5 ± 0.25
5 mM 0.76 ± 4.72 14 ± 0.50
10 mM 65.90 ± 4.66*† 89 ± 3.75*
*Significantly different when compared to control (p < 0.05) †These 
data are not considered significant due to associated high cell 
mortality that may be the result of secondary DNA damage from 
cytotoxic injury. DNA damage (measured as strand breaks by the 
DNA alkaline unwinding assay, DAUA) is reported as percent control 
damage ± standard error. The cytotoxicty of PRH was measured by 
the amount of cellular lactate dehydrogenase (LDH) at the conclusion 
of the exposure. Mean values are the percent maximum release ± SE; 
DAUA and LDH assays were performed in triplicate.Journal of Carcinogenesis 2004, 3 http://www.carcinogenesis.com/content/3/1/2
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due to the high degree of cell mortality that may have ele-
vated the levels of DNA SB via secondary damage from
cytotoxic injury. All treatments that showed positive
recovery also showed acceptable and near identical viabil-
ity at 2 and 24 hr. These data imply that DBCM at 10 mM
and TBM at 1 mM continue to damage DNA following
removal of cells from exposure media, and TBM at 5- and
10-mM also continue to damage DNA concurrently with
additional cell mortality over 22 hr.
A possible explanation for the lack of recovery in DBCM
and TBM exposed CCRF-CEM cells may be the higher
octanol/water partition coefficients (log Pow) of the more
brominated THMs. The Pow is a measure of a compound's
lipophilicity and an indication of its ability to cross cell
membranes. All of the THMs are slightly lipophilic with a
Pow of 1.97, 2.1, 2.24, and 2.38 for TCM, BDCM, DBCM,
and TBM, respectively [20,21]. Furthermore, the partition
coefficients of TCM and BDCM are 203 and 526 in fat,
respectively and 21.1 and 30.6 in liver respectively
[22,23]. Although the CCRF-CEM cells that were exam-
ined for DNA SB recovery were placed into fresh media
following the 2-hr exposure, the more lipophilic THMs
may have remained in the cells longer and thus contrib-
uted to additional DNA SB.
Toxicological studies have demonstrated that 50 and 100
mg/kg BDCM and 100 and 200 mg/kg TBM administered
by corn oil gavage induced colorectal adenocarcinoma in
male and female F344/N rats [24,25]. The increased inci-
dence of colorectal cancer was concordant with findings
from epidemiologic studies. However, a recently com-
pleted 2-year bioassay of BDCM administered in the
drinking water to male F344/N rats failed to demonstrate
colorectal neoplasia [26]. Although BDCM in the drinking
water did not increase the incidence of colorectal cancer in
rats, exposure to the brominated THMs in the drinking
water did induce aberrant crypt foci (ACF) [8]. ACF are
collections of abnormal colonic crypts that are character-
ized by hyperproliferation, increased size, expanded peric-
ryptal zones, and elongated or serrated crypt lumens. ACF
are considered to be early putative preneoplastic lesions of
colon neoplasia [10,11].
Studies have shown that alterations in the cells ability to
repair DNA is an early event in the formation of ACF
[27,28]. In this study, CCRF-CEM cells exposed to DBCM
and TBM appeared to have compromised DNA repair
capacity as demonstrated by an increase accumulation of
DNA SB following exposure. Current work in our lab on
F344/N rats show a significant increase in ACF as the
number of bromine atoms on the THM increases. One
possible explanation may be that rats exposed to bromi-
nated THMs may have decreased DNA repair capacity and,
as a result, be more disposed to ACF development. Future
studies are planned to examine this hypothesis.
The relationship between brominated THM metabolism
and toxicity is not completely understood; however, a
theta-class glutathione S-transferase known as GSTT1-1,
the protein product of the GSTT1-1 gene, catalyzes the for-
mation of mutagenic intermediates from brominated
THMs. [29-31]. These intermediates have recently been
shown to covalently bind DNA and produce deoxyguano-
sine adducts in vitro [32]. GSTT1-1  is polymorphic in
humans with 20–25% of Caucasians and 50% of Asians
having a homozygous deletion of this gene resulting in a
null genotype [33-35]. GSTT1-1 has also been detected in
F344/N rat tissues [36,37]. In vitro results suggest that
people with at least one copy of the GSTT1-1 gene might
be more susceptible to the genotoxic effects of the bromi-
nated THMs than those missing the gene.
In this study, the presence of the GSTT1-1 gene was con-
firmed in CCRF-CEM cells, however no enzyme activity
was detected. This implies that CCRF-CEM human lym-
phoblastic leukemia cells do not express the GSTT1-1
enzyme or that levels of functional enzyme were less than
the detection limit of the assay. This result correlates with
the finding that human lymphocytes also lack GSTT1-1
activity [38,39]. Nevertheless, it has been reported that
CCRF-CEM cells do express GST activity toward the uni-
versal GST substrate 1-chloro-2,4-dinitrobenzene [40],
suggesting the expression of GST alpha, mu, and pi iso-
forms. These findings raise the question of whether
brominated THMs act by two different mechanisms to: 1)
induce GSTT1-1-dependent mutations in Salmonella, and
2) produce DNA SB in CCRF-CEM cells, apparently inde-
pendent of significant metabolism by GSTT1-1.
PRH exposed to 10-mM DBCM or TBM for 4 hr produced
significant DNA SB. These data are similar to those
reported for CCRF-CEM cells where both the high 10-mM
concentrations of DBCM and TBM caused significant
increases in DNA SB. A 2-fold increase in DNA SB was
observed between CCRF-CEM cells exposed to 5- or 10-
mM DBCM or TBM; however, an 8- and 86-fold increase,
respectively was seen in PRH. At low concentrations, PRH
may have utilized protective or repair mechanisms that
were less efficient in the CCRF-CEM cells, which are not
known to express any cytochrome P450 enzyme activity
and are essentially devoid of enzymes that can activate
carcinogens to DNA-reactive metabolites [13]. A compar-
ison of DNA SB dose-response linearity between CCRF-
CEM cells and PRH for DBCM and TBM yielded r2 values
of 0.990 and 0.991 for CCRF-CEM cells, respectively, and
r2 values of 0.576 and 0.622 for PRH. This may suggest a
threshold concentration in PRH for DNA damage
between 5 and 10 mM for both DBCM and TBM. Further-Journal of Carcinogenesis 2004, 3 http://www.carcinogenesis.com/content/3/1/2
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more, cytotoxicity was increased proportionally with dose
and may have contributed to the levels of DNA SB
observed at 10-mM DBCM or TBM.
No DNA SB in liver, kidney, or duodenum epithelial cells
were observed in F344/N rats exposed to each THM by a
single oral gavage (0.3 or 0.6 mM/kg), for 2 weeks in
drinking water (0.6, 1.2 or 2.4 g/L), or BDCM for 5 weeks
in drinking water (0.6, 1.2 or 2.4 g/L). Although no DNA
SB were observed in the tissues listed above, future studies
are planned to evaluated DNA damage and repair in the
colon of F344/N rats following THM exposure.
Conclusions
CCRF-CEM cells, exposed to the brominated THMs at 5 or
10 mM for 2 hr showed a significant increase in DNA SB
when compared to control cells. Additionally, CCRF-CEM
cells exposed to DBCM and TBM appeared to have com-
promised DNA repair capacity as demonstrated by an
increased amount of DNA SB at 22 hr following exposure.
CCRF-CEM cells were found to be positive for the GSTT1-
1 gene, however no activity was detected. PRH exposed to
10-mM DBCM or TBM for 4 hr produced significant DNA
SB, however, cytotoxicity was increased proportionally
with dose and may have contributed to the observed
increase. No DNA SB were observed in liver, kidney, or
duodenum epithelial cells of F344/N rats exposed to indi-
vidual THMs by a single oral gavage, for 2 weeks in drink-
ing water, or BDCM for 5 weeks in drinking water.
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